• Email
  • Help

This page brings together the Agency's latest information on diabetes.

It lists:

the ten newest and recently updated medicines authorised for the treatment of diabetes in the European Union (EU);

the most recent opinions on anti-diabetes medicines that are pending authorisation by the European Commission (EC);

the latest diabetes-related news and press releases;

the Agency's events on diabetes-related topics.

New and recently updated medicines

Opinions pending EC decision



  • 25/02/2013


    Workshop on paediatric investigation plans in type-2 diabetes mellitus

    This workshop focuses on aspects of paediatric clinical trials in type-2 diabetes mellitus (T2DM). Experts in the field, together with regulators and the pharmaceutical industry discuss suitable inclusion criteria, outcome measures and study designs in paediatric investigation plans in T2DM and approaches to enhance trial feasibility. Expressions of interest to be sent by 11/02/2013. Registration by invitation only. ... Read more

  • 17/04/2009


    Meeting of the paediatric diabetes mellitus expert group

    This meeting is aiming to identify the best possible research approaches for new medication in the field of diabetes in childhood and adolescence. Participants have been sent the questions in advance, with a request to submit short answers in writing, to be discussed during the meeting. ... Read more